Promethium Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Hold
1,000
0.58% 49
2026
Q1
$920K Hold
1,000
0.48% 59
2025
Q4
$1.07M Hold
1,000
0.58% 53
2025
Q3
$763K Hold
1,000
0.44% 60
2025
Q2
$780K Hold
1,000
0.47% 59
2025
Q1
$826K Hold
1,000
0.53% 51
2024
Q4
$772K Hold
1,000
0.53% 55
2024
Q3
$886K Buy
+1,000
New +$899K 0.63% 46

Other funds holding LLY

Promethium Advisors's LLY Position: Q2 2026 in Review

Promethium Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 1,000 shares worth $1.2M. The position accounts for 0.58% of the portfolio, ranked #49.

Promethium Advisors first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Promethium Advisors held 1,000 shares of Eli Lilly worth $1.2M as of Q2 2026.
  • Promethium Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.58% of Promethium Advisors's portfolio in Q2 2026, its #49 holding.
  • Promethium Advisors first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Promethium Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.